Two phase III trials of baricitinib for alopecia areata: a critically appraised research paper. McSweeney SM, Rayinda T, McGrath JA, Tziotzios C, et al. Br J Dermatol 2023;188:195-197.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

McSweeney SM, Rayinda T, McGrath JA, Tziotzios C, et al. Two phase III trials of baricitinib for alopecia areata: a critically appraised research paper. Br J Dermatol 2023;188:195-197.
PMID: 36763859